We are a drug discovery and development company focused on the CNS area. We have a robust IP portfolio comprising composition of matter patents and a platform technology patent (sublicensed to Cerca Insights to provide screening services). We have identified 6 biological active leads through this platform technology and are currrently in the preclinical stage.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
